Clinical Trial Update: Switch From Oral Iron to Intravenous Ferric Carboxymaltose in Non-dialysis Chronic Kidney Disease (CKD) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reports switching from oral iron to intravenous ferric carboxymaltose in non-dialysis chronic kidney disease patients with iron de…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• Ferric carboxymaltose (ferric carboxymaltose)

Snippet

Sponsor: Hospital Aleman | Conditions: Iron Deficiency, Anaemia | Phase 4 | Status: COMPLETED